BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21995658)

  • 1. Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates.
    Lackner M; Rezusta A; Villuendas MC; Palacian MP; Meis JF; Klaassen CH
    Mycoses; 2011 Oct; 54 Suppl 3():12-21. PubMed ID: 21995658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
    Lackner M; de Hoog GS; Verweij PE; Najafzadeh MJ; Curfs-Breuker I; Klaassen CH; Meis JF
    Antimicrob Agents Chemother; 2012 May; 56(5):2635-42. PubMed ID: 22290955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human and animal isolates of Pseudallescheria boydii and Scedosporium species, from Melbourne, Australia, 1977-1995.
    Maslen M; Peel M
    Mycoses; 2011 Sep; 54(5):442-9. PubMed ID: 20492531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection.
    Heath CH; Slavin MA; Sorrell TC; Handke R; Harun A; Phillips M; Nguyen Q; Delhaes L; Ellis D; Meyer W; Chen SC;
    Clin Microbiol Infect; 2009 Jul; 15(7):689-93. PubMed ID: 19549223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of German Scedosporium prolificans cases from 1993 to 2007.
    Tintelnot K; Just-Nübling G; Horré R; Graf B; Sobottka I; Seibold M; Haas A; Kaben U; De Hoog GS
    Med Mycol; 2009 Jun; 47(4):351-8. PubMed ID: 19301173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-identification of clinical isolates of the Pseudallescheria boydii-complex involved in near-drowning.
    Tintelnot K; Wagner N; Seibold M; de Hoog GS; Horré R
    Mycoses; 2008 Sep; 51 Suppl 3():11-6. PubMed ID: 18782237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.
    Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2007 Feb; 51(2):748-51. PubMed ID: 17101671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex.
    Hedayati MT; Tavakoli M; Maleki M; Heidari S; Mortezaee V; Gheisari M; Hassanzad M; Mirenayat MS; Mahdaviani SA; Pourabdollah M; Velayati AA; Vakili M; Abastabar M; Haghani I; Jafarzadeh J; Hedayati N; Seyedmousavi S; Alastruey-Izquierdo A
    Microb Pathog; 2019 Apr; 129():168-175. PubMed ID: 30742949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination of Scedosporium prolificans against Pseudallescheria boydii and Scedosporium apiospermum by semiautomated repetitive sequence-based PCR.
    Steinmann J; Schmidt D; Buer J; Rath PM
    Med Mycol; 2011 Jul; 49(5):475-83. PubMed ID: 21108573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular identification tools for sibling species of Scedosporium and Pseudallescheria.
    Lackner M; Klaassen CH; Meis JF; van den Ende AH; de Hoog GS
    Med Mycol; 2012 Jul; 50(5):497-508. PubMed ID: 22004363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of the different species of the Pseudallescheria boydii/Scedosporium apiospermum complex in French patients with cystic fibrosis.
    Zouhair R; Rougeron A; Razafimandimby B; Kobi A; Bouchara JP; Giraud S
    Med Mycol; 2013 Aug; 51(6):603-13. PubMed ID: 23461512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse line blot hybridisation screening of Pseudallescheria/Scedosporium species in patients with cystic fibrosis.
    Lu Q; van den Ende AH; de Hoog GS; Li R; Accoceberry I; Durand-Joly I; Bouchara JP; Hernandez F; Delhaes L
    Mycoses; 2011 Oct; 54 Suppl 3():5-11. PubMed ID: 21995657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium.
    Sedlacek L; Graf B; Schwarz C; Albert F; Peter S; Würstl B; Wagner S; Klotz M; Becker A; Haase G; Laniado G; Kahl B; Suerbaum S; Seibold M; Tintelnot K
    J Cyst Fibros; 2015 Mar; 14(2):237-41. PubMed ID: 25595044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New record of Scedosporium dehoogii from Chile: Phylogeny and susceptibility profiles to classic and novel putative antifungal agents.
    Alvarez E; Sanhueza C
    Rev Iberoam Micol; 2016; 33(4):224-229. PubMed ID: 27461998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilocus sequence typing of Scedosporium apiospermum and Pseudallescheria boydii isolates from cystic fibrosis patients.
    Bernhardt A; Sedlacek L; Wagner S; Schwarz C; Würstl B; Tintelnot K
    J Cyst Fibros; 2013 Dec; 12(6):592-8. PubMed ID: 23764085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
    Schemuth H; Dittmer S; Lackner M; Sedlacek L; Hamprecht A; Steinmann E; Buer J; Rath PM; Steinmann J
    Mycoses; 2013 May; 56(3):297-303. PubMed ID: 23170818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
    Wiederhold NP; Law D; Birch M
    J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group.
    Berenguer J; Rodríguez-Tudela JL; Richard C; Alvarez M; Sanz MA; Gaztelurrutia L; Ayats J; Martinez-Suarez JV
    Medicine (Baltimore); 1997 Jul; 76(4):256-65. PubMed ID: 9279332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Pathogenicity of Lomentospora prolificans (Scedosporium prolificans) Isolates from Mexican Patients.
    Elizondo-Zertuche M; Montoya AM; Robledo-Leal E; Garza-Veloz I; Sánchez-Núñez AL; Ballesteros-Elizondo R; González GM
    Mycopathologia; 2017 Aug; 182(7-8):681-689. PubMed ID: 28456868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases.
    Rodriguez-Tudela JL; Berenguer J; Guarro J; Kantarcioglu AS; Horre R; de Hoog GS; Cuenca-Estrella M
    Med Mycol; 2009 Jun; 47(4):359-70. PubMed ID: 19031336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.